| Literature DB >> 31676068 |
Wenhui Yu1, Xianqing Lan1, Jie Cai1, Xueqing Wang1, Xiaomei Liu1, Xiangdong Ye1, Qing Yang1, Yanting Su1, Bo Xu1, Tielong Chen2, Lingyun Li3, Hui Sun4.
Abstract
Acute liver failure (ALF) can be the consequence of various etiologies, which immune response plays a pivotal role in the pathogenesis. For the diversity of etiologies, more animal models are still needed in this field. Here, we developed a new acute liver injury mouse model induced by a fungal lectin AAGL (Agrocybe aegerita galectin). Intravenous injection of AAGL could induce the infiltration and activation of T, NKT and NK cells in liver and T cell played an important role in the pathogenesis. However, compared with the widely used concanavalin A model, AAGL model showed different immune mechanism. Transcriptome analysis of live tissue suggested that inflammation mediated by chemokine and cytokine signaling pathway was different between AAGL and Con A model. Fluorescent quantitative PCR verification assay showed that IL-1β was expressed much higher in AAGL-treated mice and anti-IL-1β could ameliorate AAGL-induced liver injury by inhibiting NF-κB and p38 signaling pathway. The expression of CXCL9 which was responsible for T cell infiltration in liver was also inhibited in AAGL model. We found a critical role of IL-1β in the pathogenesis of AAGL model through recruiting T cells to liver, which highlighted that IL-1β antibody might be a candidate therapy for ALF.Entities:
Keywords: ALF; Agrocybe aegerita galectin; Cytokines and chemokines; IL-1β; Mouse model
Mesh:
Substances:
Year: 2019 PMID: 31676068 DOI: 10.1016/j.bbrc.2019.10.087
Source DB: PubMed Journal: Biochem Biophys Res Commun ISSN: 0006-291X Impact factor: 3.575